Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

NCT00070655 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4673

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: SR34006 (idraparinux sodium) Injection
DRUG: vitamin K antagonist (warfarin or acenocoumarol) tablets

Sponsor

Sanofi